Metraipolis › archive › dc_2b78724dce05

Navigating the USPTO's AI inventorship guidance in AI-driven drug discovery — Europe PMC PMID:40756952

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40756952
DOI
10.1093/jlb/lsaf014
License (as archived)
solo-consultazione
Archived
2026-10-07T14:41:19.736Z
SHA-256 of the archived text
9dcf3444ade41ce55e7064efa901a88330ad443d48fbb9f3c0a338d92e809d9b
Stable URL of this page
https://metraipolis.com/documento/dc_2b78724dce05

How to cite

Navigating the USPTO's AI inventorship guidance in AI-driven drug discovery — Europe PMC PMID:40756952 — Europe PMC (en), https://europepmc.org/article/MED/40756952 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b78724dce05 (Metraipolis archive dc_2b78724dce05, sha256 9dcf3444ade41ce55e7064efa901a88330ad443d48fbb9f3c0a338d92e809d9b)
BibTeX
@misc{dc2b78724dce05,
  title = {Navigating the USPTO's AI inventorship guidance in AI-driven drug discovery — Europe PMC PMID:40756952},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40756952},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b78724dce05; sha256 9dcf3444ade41ce55e7064efa901a88330ad443d48fbb9f3c0a338d92e809d9b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40756952. Agents can read the archived copy with the MCP tool read_document.